In addition to COXs and PPAR-γ, several alternative molecular targets can account for the broad protective effects of these compounds against a variety of pathological conditions, with or without a prominent flogistic base, including colon cancer, cardiovascular and neurodegenerative diseases. Here, PPARG is linked to neurodegenerative disease.